Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

863 studies match

clinicaltrialsPublishedShowing 1–50 of 863 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05128825	A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer(DENALI)	recruiting	Phase 2	310	K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncINDUSTRY	8	Sep 29, 2026	clinicaltrials
NCT05827081	Phase IIIb Study of Ribociclib + ET in Early Breast Cancer(Adjuvant WIDER)	recruiting	Phase 3	1,400	Novartis Pharmaceuticals